Rituximab for the treatment of multiple sclerosis: a review

CG Chisari, E Sgarlata, S Arena, S Toscano, M Luca… - Journal of …, 2022 - Springer
In the last decades, evidence suggesting the direct or indirect involvement of B cells on
multiple sclerosis (MS) pathogenesis has accumulated. The increased amount of data on …

Primary CNS lymphoma

C Grommes, LM DeAngelis - Journal of Clinical Oncology, 2017 - ascopubs.org
Primary CNS lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin lymphoma that is
typically confined to the brain, eyes, and cerebrospinal fluid without evidence of systemic …

Targeting Pim kinases in hematological cancers: molecular and clinical review

M Bellon, C Nicot - Molecular Cancer, 2023 - Springer
Decades of research has recognized a solid role for Pim kinases in lymphoproliferative
disorders. Often up-regulated following JAK/STAT and tyrosine kinase receptor signaling …

Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection

F Ma, L Yang, Z Sun, J Chen, X Rui, Z Glass, Q Xu - Science advances, 2020 - science.org
Safe and efficient delivery of blood-brain barrier (BBB)–impermeable cargos into the brain
through intravenous injection remains a challenge. Here, we developed a previously …

Rituximab: mechanism of action

GJ Weiner - Seminars in hematology, 2010 - Elsevier
Rituximab is a mainstay in the therapy for a broad variety of B-cell malignancies. Despite its
undeniable therapeutic value, we still do not fully understand the mechanisms of action …

Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma

JL Rubenstein, H Geng, EJ Fraser, P Formaker… - Blood …, 2018 - ashpublications.org
There is an unmet need for effective biological therapies for relapsed central nervous system
(CNS) lymphoma. Lenalidomide is active in activated B-cell type diffuse large B-cell …

Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma

C Grommes, JL Rubenstein, LM DeAngelis… - Neuro …, 2019 - academic.oup.com
Primary central nervous system lymphoma (PCNSL) is a rare form of non-Hodgkin
lymphoma that affects the brain parenchyma, spinal cord, eyes, and cerebrospinal fluid …

First-in-man intrathecal application of neurite growth-promoting anti-Nogo-A antibodies in acute spinal cord injury

K Kucher, D Johns, D Maier, R Abel… - … and Neural Repair, 2018 - journals.sagepub.com
Background. Neutralization of central nervous system neurite growth inhibitory factors, for
example, Nogo-A, is a promising approach to improving recovery following spinal cord injury …

Physiology of blood–brain interfaces in relation to brain disposition of small compounds and macromolecules

N Strazielle, JF Ghersi-Egea - Molecular pharmaceutics, 2013 - ACS Publications
The brain develops and functions within a strictly controlled environment resulting from the
coordinated action of different cellular interfaces located between the blood and the …

Primary testicular lymphoma

CY Cheah, A Wirth, JF Seymour - Blood, The Journal of the …, 2014 - ashpublications.org
Primary testicular lymphoma (PTL) is a rare, clinically aggressive form of extranodal
lymphoma. The vast majority of cases are histologically diffuse large B-cell lymphoma, but …